This company has been acquired
GreenLight Biosciences Holdings Dividend
Dividend criteria checks 0/6
GreenLight Biosciences Holdings does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
| Industry average yield | 2.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Earnings per share | -US$1.04 |
| Dividend yield forecast in 3Y | 0% |
Recent dividend updates
No updates
Recent updates
GreenLight Biosciences cutting 25% of staff as part of realignment
Oct 12GreenLight Biosciences launches $109M in financing
Aug 12GreenLight Biosciences, Samsung Biologics complete commercial-scale engineering run for mRNA COVID-19 vaccine
Aug 01GreenLight Biosciences: Synthesizing Cell-Free RNA
Apr 05Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if GRNA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if GRNA's dividend payments have been increasing.
Dividend Yield vs Market
| GreenLight Biosciences Holdings Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (GRNA) | n/a |
| Market Bottom 25% (US) | 1.5% |
| Market Top 25% (US) | 4.6% |
| Industry Average (Biotechs) | 2.7% |
| Analyst forecast in 3 Years (GRNA) | 0% |
Notable Dividend: Unable to evaluate GRNA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate GRNA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as GRNA has not reported any payouts.